Podcast with Dr Bijoor and Kari Beal from Fox Carolina.
https://podcasts.apple.com/us/podcast/how-a-doctor-is-helping-patients-wean-off-glp-1s/id1847442895?i=1000746005743
I recently sat down with Dr. Nita Bijoor of Oakview Medical Associates and Kari Beal to talk about my weight loss journey and how Zepbound (tirzepatide) helped me push past a tough plateau.
After dropping about 50 pounds through diet and exercise, I hit the classic stall: no progress for a month, plus nagging joint inflammation that left me demotivated and ready to quit.
Experts often advise sticking it out, but the frustration was real. That's when Dr. Bijoor recommended Zepbound, a dual GLP-1/GIP agonist. Emerging research shows tirzepatide reduces inflammatory markers like hsCRP and IL-6—beyond just weight loss effects—which aligned with my experience of eased joint issues and renewed momentum.
It broke the plateau, reigniting fat loss. But Zepbound isn't magic or a shortcut. You still need solid habits: clean eating, regular exercise (especially strength training to preserve muscle), and close physician monitoring.
It quiets "food noise," curbs pantry raids, and steers you toward smarter choices—almost eerily effective.
If you're struggling with a similar stall or inflammation during weight loss, talk to your doctor. Results vary, but for me, it was a game-changer in a sustainable way.

